A signed term sheet or an investor's verbal yes does not put money in your bank account. Venture capital approval is a commitment to fund, not the funding itself, and the gap between the two is where startups get into trouble. Reporting on Korean startups by Chloe Kim at KoreaTechDesk describes exactly this scenario: a company secures approval, finalizes expansion plans, and prepares to hire—only to find the expected investment has not arrived, because the fund may still be collecting capital or the payment depends on conditions the startup has yet to satisfy.

The good news is that both major categories of delay—investor-side fund mechanics and startup-side unmet conditions—are largely manageable before you sign. This guide lays out how each risk works and gives you a decision framework for the due diligence and term sheet negotiation phases.

Understanding Venture Capital Disbursement Risks

Disbursement risk is the possibility that committed capital arrives late, in part, or not at all after investors have expressed willingness to invest. As KoreaTechDesk's coverage puts it, "VC approval does not guarantee immediate disbursement." The risk emerges in the window between signing and the wire, when hiring commitments, product launches, and expansion plans are already in motion and depend on resources arriving on schedule.

Two distinct failure modes drive most delays. The first lives inside the venture fund itself: the firm has committed to invest but has not yet collected the underlying capital from its limited partners. The second lives inside your company: the deal is conditioned on closing requirements you have not yet satisfied. Treating these as separate problems matters, because they have different diagnostics and different contractual remedies.